The global subarachnoid hemorrhage surgical devices market is estimated to garner sizeable revenue by growing at a significant CAGR over the forecast period, i.e., 2022–2030. The growth of the market can be attributed to the increasing demand for surgical treatment for subarachnoid hemorrhage (SAH), backed by the mounting cases of SAH, especially in the older population. Various lifestyle factors, such as, smoking, excessive drinking, cocaine abuse, high blood pressure, and others, along with family history of SAH and certain connective tissue disorders are the major causes for SAH in any individual. In this disease, certain vein in the brain swells and ruptures, which causes bleeding between the brain and skull. This causes clotting of blood in skull, which is deadly. The primary aim of the surgeries is to ensure the vein does not rupture and bleed again, for which various devices are used. The increasing cases of SAH backed by poor lifestyle and lack of routine health checkups, are estimated to boost the market growth. Along with this, increasing government initiatives to improve healthcare system and provide affordable treatments to all, in the form of insurance, reimbursements, and subsidies, are further expected to contribute to the growth of the market.
Get more information on this report: Download Sample PDF
The global subarachnoid hemorrhage surgical devices market is divided by surgery type into endovascular surgery, and open surgery, out of which, the endovascular surgery segment is anticipated to hold the notable revenue share in the market during the forecast period as this is minimally invasive and less risky as compared to open surgery, which is why people prefer it, if the condition allows. However, the surgery depends on the condition of the patients.
On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers, and others, out of which the ambulatory surgical centers segment is anticipated to grow significantly throughout the forecast period. This can be attributed to the growing acceptance of ASCs as they are less expensive, specialized, and better equipped for surgeries. Moreover, this segment is expected to witness growth in developed nations, owing to higher health awareness amongst the people, whereas, hospital segment is estimated to dominate the market in developing countries. CLICK TO DOWNLOAD SAMPLE REPORT
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Regionally, the global subarachnoid hemorrhage surgical devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America region is estimated to garner largest share over the forecast period on the back of availability of advanced health equipment and technology in the region, along with higher healthcare expenditure. According to the World Health Organization (WHO), as of 2018, 16.416 % of the GDP was spent on the healthcare sector in North America. Moreover, increasing investments by major market players on research and development activities for the development of newer treatment methods are estimated to contribute towards the market growth in the forecast period.
The market in the Asia Pacific region is estimated to witness highest CAGR over the forecast period on account of increasing healthcare awareness amongst the people in developing nations, including, Japan, China, India, and Indonesia, along with rising disposable income. Moreover, constant development in the public healthcare system in the APAC region is also expected to positively affect the market.
Get more information on this report: Download Sample PDF
The global subarachnoid hemorrhage surgical devices market is further classified on the basis of region as follows:
Our in-depth analysis of the global subarachnoid hemorrhage surgical devices market includes the following segments:
FREQUENTLY ASKED QUESTIONS
Rising prevalence of SAH and growing R&D investment for medical research are the major factors driving the market growth.
The market is anticipated to attain a significant CAGR over the forecast period, i.e., 2022-2030.
High cost of treatment and complications associated with the surgery are the major factors estimated to hamper the market growth.
The market in the North America is estimated to provide most growth opportunities owing to the region’s high healthcare expenditure and R&D investment during the forecast period.
The major players in the market are Stryker Corporation, Abbott Laboratories, General Electric Company, Terumo Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by device type, surgery type, end-user, and by region.
The ambulatory surgical centers segment is anticipated to hold largest market size on the back of focused and more effective treatment facilities.
Select License Type
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization